Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Julia Shirvan"'
Autor:
Young Eun Huh, Hyejung Park, Ming Sum Ruby Chiang, Idil Tuncali, Ganqiang Liu, Joseph J. Locascio, Julia Shirvan, Samantha J. Hutten, Melissa S. Rotunno, Catherine Viel, Lamya S. Shihabuddin, Bing Wang, Sergio Pablo Sardi, Clemens R. Scherzer
Publikováno v:
npj Parkinson's Disease, Vol 7, Iss 1, Pp 1-7 (2021)
Abstract Protein-coding variants in the GBA gene modulate susceptibility and progression in ~10% of patients with Parkinson’s disease (PD). GBA encodes the β-glucocerebrosidase enzyme that hydrolyzes glucosylceramide. We hypothesized that GBA muta
Externí odkaz:
https://doaj.org/article/55051a3035eb4ec194cc1bc0ad51cd1d
Autor:
Christopher Simpson, Lisa Vinikoor-Imler, Feiby L. Nassan, Julia Shirvan, Cathy Lally, Tien Dam, Nancy Maserejian
Publikováno v:
Parkinsonism & Related Disorders. 98:103-113
Variants in the leucine-rich repeat kinase 2 gene (LRRK2) are risk factors for Parkinson's disease (PD), but their prevalence varies geographically, reflecting the locations of founder events and dispersion of founders' descendants.A comprehensive li
Autor:
Ganqiang Liu, Catherine Viel, Clemens R. Scherzer, Joseph J. Locascio, Ming Sum Ruby Chiang, Samantha J. Hutten, Hyejung Park, Idil Tuncali, Bing Wang, Julia Shirvan, Lamya S. Shihabuddin, Melissa S. Rotunno, Sergio Pablo Sardi, Young Eun Huh
Publikováno v:
npj Parkinson's Disease, Vol 7, Iss 1, Pp 1-7 (2021)
NPJ Parkinson's Disease
NPJ Parkinson's Disease
Protein-coding variants in the GBA gene modulate susceptibility and progression in ~10% of patients with Parkinson’s disease (PD). GBA encodes the β-glucocerebrosidase enzyme that hydrolyzes glucosylceramide. We hypothesized that GBA mutations wil
Autor:
Aaron P. Schultz, Stephen N. Gomperts, Nathan F. Clement, Rong Ye, Samantha Katz, Matthew P. Frosch, Julia Shirvan, John H. Growdon, Keith A. Johnson, Teresa Gomez-Isla
Publikováno v:
Neurology
ObjectiveTo develop imaging biomarkers of diseases in the Lewy body spectrum and to validate these markers against postmortem neuropathologic findings.MethodsFour cognitively normal participants with Parkinson disease (PD), 4 with PD with cognitive i